Angiopoietin-like protein as a novel marker for liver fibrosis in chronic hepatitis B patients with normal to minimally raised ALT

BACKGROUND: For hepatitis B patients who do not meet the treatment criteria recommended by guidelines, therapy decisions depend on hepatic histology. Angiopoietin-like protein 2 (Angptl2) is a mediator of chronic inflammation that contributes to extracellular matrix remodeling. The aim of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Yongqiong, Zhao, Hong, Zhou, Jiyuan, Yan, Linlin, Wang, Guiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622570/
https://www.ncbi.nlm.nih.gov/pubmed/28962551
http://dx.doi.org/10.1186/s12879-017-2728-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622570/
https://www.ncbi.nlm.nih.gov/pubmed/28962551
http://dx.doi.org/10.1186/s12879-017-2728-7

Ejemplares similares